The purpose of this randomized controlled trial is to evaluate a fully automated algorithm for the establishment of glycemic control in diabetic patients and to compare the results with routine management of hyperglycemia in patients undergoing cardiopulmonary bypass surgery.
Name: Space Glucose ControlDescription: Development of a closed loop control system via Space Glucose Control that automatically infuses insulin on the basis of an automated algorithm, which integrates a continuous glucose signal, could help overcome these obstacles and permit strict glycemic control without increasing the workload.Type: Device
Space Glucose Control
Description: The reduction of this percentage to less than 10% with the fully automated algorithm as clinically significantMeasure: Percentage of patients who will have a serum glucose level between 140-180mg/dl during surgery. Time: Approximately 1 year
There is one SNP
The same intervention will be repeated in case this level wasn't reached and patient will be withdrawn from the study after two failed correction and will be treated more aggressively with an infusion of D10W. --- D10W ---